Vvus stock earnings report pcosias

Vvus stock earnings report

23.03.2021

Weisberger24571

VVUS VIVUS, Inc. Stock Quote - FINVIZ.com VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in VIVUS - VVUS - Stock Price & News | The Motley Fool Real time VIVUS (VVUS) stock price quote, stock graph, Earnings Call Transcripts; The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Let VVUS Stock Price & Charts | VIVUS In depth view into VVUS (VIVUS) stock including the latest price, news, dividend history, earnings information and financials. VVUS:NASDAQ GS Stock Quote - VIVUS Inc - Bloomberg Markets

Vivus Inc. (VVUS) Earnings - Stock Options Trading Tools

Vivus Inc. (VVUS) Earnings - Stock Options Trading Tools Find stock price reaction to earnings announcements for Vivus Inc. (VVUS). Table displays both upcoming quarterly earnings dates and historical release dates as well as stock price changes, if available. For stocks that list options, compare implied volatility before and after earnings dates, as well as the option market's expected versus actual price movement.

VIVUS, Inc. is estimated to report earnings on 05/05/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting

Vivus Inc : VVUS Earnings Reports at Ally Invest Get free earnings reports and analysis for Vivus Inc (VVUS) at Ally Invest. Quotes Snapshot > VVUS. Vivus Inc VVUS:NASDAQ. Set Alert Options Streaming Charts. Last Price $1.77 NASDAQ Previous Close - Last Trade as of 3:59PM ET 3/02/20. Today's Change 0.00 (0.00%) Bid (Size) $1.21 (6) Stock Earnings - TD Ameritrade

VIVUS stock rating and analysis - VVUS : a summary of key financial strength and GuruFocus has detected 5 Severe warning signs with VVUS. Earnings Yield (Greenblatt) %, -4.85 The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect

VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in VVUS.US | VIVUS Inc. Stock Price & News - WSJ Nov 02, 2019 · View the latest VIVUS Inc. (VVUS.US) stock price, news, historical charts, analyst ratings and financial information from WSJ. DOW JONES, A NEWS CORP COMPANY News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.

VVUS Stock Price Quote & News - VIVUS | Robinhood

VIVUS, Inc. (VVUS) latest earnings report: revenue, EPS, surprise, history, news and analysis. Earnings. VIVUS (NASDAQ:VVUS) Earnings Information. VIVUS last issued its quarterly earnings data on March 3rd, 2020. The biopharmaceutical company Find the latest and the upcoming Vivus earnings report Mar 23, 2020 as well as The TipRanks Smart Score analyzes stocks based on 8 factors extracted from Find the latest VIVUS, Inc. (VVUS) stock quote, history, news and other vital Edited Transcript of VVUS earnings conference call or presentation 3-Mar-20 Vivus Stock Chart and Information. NASDAQ: VVUS. Apr 6, 2020 4:00 PM EDT. Price: $1.31 Results 1 - 10 of 77 March 3, 2020, VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results.